Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Intergroupe Francophone de Cancerologie Thoracique"
Count: 58
Selected: 0
NCT03591731Nivolumab +/- Ipilimumab in Patients With Advanced, Refractory Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Tumors (NECs)
NCT05856695A Phase II Study Assessing the Efficacy of Etoposide Free Chemotherapy Plus Durvalumab (MEDI4736) in First Line Extensive Disease Small Cell Lung Cancer (SCLC)
NCT04621188Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)
NCT04233021Study of Osimertinib in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation
NCT03845270Her2-positive Lung Cancer Treated With Dedicated Drug
NCT04526782ENCOrafenib With Binimetinib in bRAF NSCLC
NCT04108026Immunotherapy in Patient With Poor General Condition
NCT03977194Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy
NCT05273047RW Efficacy of Sotorasib in KRAS G12C-mutated Metastatic NSCLC
NCT05255302De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction
NCT04111705Lorlatinib After Failure of First-line Second-generation ALK Kinase Inhibitor in Patients With Advanced ALK-positive Non-small Cell Lung Cancer
NCT03469960Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr
NCT06053099A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)
NCT00651456Mesothelioma Avastin Plus Pemetrexed-cisplatin Study
NCT01700582French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular Testings
NCT05285033RW Effectiveness of Lurbinectedin in Extensive Stage SCLC
NCT03727477Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving Lorlatinib
NCT02933346Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program
NCT02727335Description of Clinical Anatomical Features and Long Term Follow-up for Patients With ALK Rearrangements
NCT02724696French National Observatory of Patients With Thymic Epithelial Tumor
NCT01465854French Biological Observatory on Lung Cancer in Never Smokers
NCT03304093Immunotherapy by Nivolumab for HIV+ Patients
NCT05781308Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy
NCT03030131Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer
NCT01850303Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer
NCT01763671Paclitaxel-bevacizumab in Advanced Lung Cancer
NCT01296113Chemotherapy for Lung Cancer in HIV-positive Patients
NCT01705184Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.
NCT05200481Study of Safety and Efficacy of Brigatinib Plus Chemotherapy or Brigatinib Only in Advanced ALK-Positive Lung Cancer (MASTERPROTOCOL ALK)
NCT05154344RW Effectiveness of Capmatinib in Advanced MET-dysregulated NSCLC Included in the French Compassionate Use Program (ATU)
NCT04920981Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
NCT04775095BRAF V600-mutated Lung Carcinoma Treated With the Combination of Dabrafenib-trametinib: a Retrospective Evaluation
NCT02716311Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer
NCT00198341Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up
NCT01102231Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)
NCT03059667Immunotherapy as Second-line in Patient With Small Cell Lung Cancer
NCT02716272Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients
NCT01556191Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR
NCT00775307Adjuvant Pazopanib in Stage I NSCLC
NCT01631136Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer
NCT00775385TAilored Post-Surgical Therapy in Early Stage NSCLC
NCT00930891Bevacizumab in Extensive Small Cell Lung Cancer
NCT00198432Chemoradiotherapy of NSCLC Stage IIIB
NCT00198354Stage I/II NSCLC Perioperative Chemotherapy
NCT00535275NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy
NCT00384826Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma
NCT00298415Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)
NCT00198393Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV
NCT00198380Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature